我院第二类精神药品应用情况与可负担性分析  

Analysis of the Utilization and Affordability of Type Ⅱ Psychotropic Substances in Our Hospital

作　　者：姜淑珍 魏波 余斌 胡茂荣 占海燕 曹晶晶[2] 

机构地区：[1]江西省精神病院药剂科,江西南昌330029 [2]中国药科大学国际医药商学院,江苏南京211198

出　　处：《药品评价》2013年第14期25-29,共5页Drug Evaluation

基　　金："我国基本药物可及性研究"。教育部人文社会科学研究规划基金项目;编号:11YJA790173

摘　　要：目的：对我院第二类精神药品的合理使用情况与可负担性情况进行分析。方法：选取我院2012年1~6月第二类精神药品处方,按用药总量、年龄、性别、疾病诊断情况等进行统计,分别按照WHO推荐的药物用药频度（DDDs）和药物利用指数（DUI）、WHO/HAI的标准方法分析药品合理使用情况和药品可负担性。结果与结论：我院使用的所有二类精神药品的DUI值均〈1.0,药物使用情况合理;大部分药品可负担性良好,劳拉西泮片可负担程度相对较低,我院应继续加强基本药物的使用。Objective： To investigate the utilization and affordability of type Ⅱ psychotropic substances in our hospital. Methods： The prescriptions of type Ⅱ psychotropic substances in our hospital from January to June in 2012 were collected and analyzed statistically in terms of the number of prescriptions including drug consumption, age ,sex and disease. According to DDDs, DUI and the standard drug price methodology of WHO/HA1, the utilization and affordability of type Ⅱ psychotropic substances in our hospital were analyzed. Results ＆ Conclusion： DUI of all kinds of type Ⅱ psychotropic substances were smaller than 1.0 in our hospital, and the affordability of drugs is better overall except lorazepam, suggesting an increase usage of the essential drug is required.

关 键 词：第二类精神药品 用药分析 可负担性 

分 类 号：R956[医药卫生—药学]